•   George Lundberg, MD

    Research paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    This paper reports the results of an investigation of the drug ONC201 in adults with recurrent glioblastoma (GBM). It found that ONC201 penetrated the blood-brain barrier and achieved intratumoral levels without toxicity. While most GBMs were not responsive, one patient with the mutation H3 K27M experienced a prolonged remission.

    Go to full paper published in Neuro-Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Targeted Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Once bladder cancer has infiltrated the muscle wall in elderly patients, it becomes challenging to treat. New drugs and immunotherapies show some promise.

    Go to full article published by Targeted Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Renal and Urology News curated by Editor in Chief George Lundberg, MD, who notes: 

    Microwave ablation has been shown to be a viable alternative to both radical and partial nephrectomy for kidney cancers that measure less than 7 cm in diameter. Outcomes for the two approaches are comparable.

    Go to full article published by Renal and Urology News.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from MedPage Today curated by Editor in Chief George Lundberg, MD, who notes: 

    Surgery is the primary treatment of choice for colorectal cancer. This enhanced  resection technique improves survival.

    Go to full article published by MedPage Today.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from ScienceDaily curated by Editor in Chief George Lundberg, MD, who notes: 

    A genetic mutation known as PPN1D has been found to be a possible point of attack for research into the childhood cancer diffuse intrinsic pontine glioma (DIPG).

    Go to full article published by ScienceDaily.

  •  

    How to Treat Uveal Melanoma that Recurs in the Liver?

    With: Emma Shtivelman, PhD

    A Q&A with Emma Shtivelman, PhD, Chief Scientist at Cancer Commons; emma@cancercommons.org Q: Malignant melanoma may arise from multiple sites, including the eye. What would you recommend be done for a 50-year-old man in the San Francisco Bay Area who was entirely well for nine years after undergoing enucleation surgery for a large uveal melanoma, but has now been informed by his physician that… Read more »

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Although generally not well recognized in the U.S., radiofrequency ablation (RFA) therapy can be highly effective in managing localized smaller lever cancers. Learn more about this treatment approach from the University of Pittsburgh Medical Center.

    .

  •  

    The Importance of Brain Tumor-Initiating Cells in Glioblastoma

    With: Anita Hjelmeland, PhD

    A Q&A with Anita Hjelmeland, PhD, Associate Professor of Cell, Developmental and Integrative Biology at the University of Alabama Birmingham School of Medicine; hjelmea@uab.edu Q: The inner workings of malignant gliomas are mysterious to many of us. Why does the prognosis of patients with these tumors remain poor? A: Glioblastoma is a primary brain tumor that is treated with surgery, radiation, and chemotherapy. While… Read more »

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Primary liver cell cancer is one of the most common causes of cancer deaths throughout the world. Usually arising in cirrhotic livers, its treatment modalities are many and varied. Cures are elusive except for liver transplantation, but many therapy modalities can sustain prolonged survival. This overview from Medscape provides useful information about the disease.

    .

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Ovarian cancer is particularly difficult; since early symptoms are few, it is often well-advanced before diagnosis. It kills more Americans than any other gynecologic malignancy. The cell types of origin vary greatly, as do treatment modalities. This multi-author 2019 review from Medscape includes established and experimental therapies.